Viewing Study NCT00916669

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:11 PM
Ignite Modification Date: 2026-01-02 @ 3:53 PM
Study NCT ID: NCT00916669
Status: WITHDRAWN
Last Update Posted: 2013-05-08
First Post: 2009-06-05
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Randomized Study to Evaluate the Effect of Two Different Doses of Enoxaparin Sodium in Combination With Standard Chemotherapy in Patients With Stage Small Cell Lung Cancer (SCLC)
Sponsor: Massachusetts General Hospital
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Small Cell Lung Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None SCLC View
None enoxaparin sodium View
None cisplatin View
None etoposide View